XML 55 R27.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Awards
 12 Months Ended
Jan. 25, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Awards Stock-Based Awards
We have outstanding stock-based awards under our 2012 Long-Term Incentive Plan, and 2017 Non-Employee Directors Equity Plan (collectively, the “Plans”). No further awards will be granted under the 2003 Long-Term Incentive Plan or 2007 Non-Employee Directors Equity Plan. As of January 25, 2025, the total number of shares available for grant under the Plans was 738,536.

In June 2024, the Company announced its CEO succession plan and transition. In connection with this transition, the Company incurred approximately $11.4 million of incremental stock-based compensation modification expense through the former CEOs retirement date of November 30, 2024 related to previously issued equity awards.

Stock-based compensation expense and the related tax benefit recognized during fiscal 2025, fiscal 2024, and fiscal 2023 were as follows (dollars in thousands):
Fiscal Year Ended
January 25, 2025January 27, 2024January 28, 2023
Stock-based compensation$40,320 $25,457 $17,927 
Income tax effect of stock-based compensation$9,718 $6,302 $4,433 

In addition, we realized approximately $9.8 million, $2.9 million, and $4.2 million of net excess tax benefits during fiscal 2025, fiscal 2024, and fiscal 2023, respectively.

As of January 25, 2025, we had unrecognized compensation expense related to stock options, RSUs, and target Performance RSUs (based on the Company’s expected achievement of performance measures) of $1.3 million, $25.2 million, and $16.0 million, respectively. This expense will be recognized over a weighted-average number of years of 2.6, 2.7, and 1.3, respectively, based on the average remaining service periods for the awards. As of January 25, 2025, we may recognize an additional $12.7 million in compensation expense in future periods if the maximum number of Performance RSUs is earned based on certain performance measures being met.

The following table summarizes the valuation of stock options and restricted share units granted during fiscal 2025, fiscal 2024, and fiscal 2023, and the significant valuation assumptions:
Fiscal Year Ended
January 25, 2025January 27, 2024January 28, 2023
Weighted average fair value of RSUs granted$154.13 $95.23 $96.81 
Weighted average fair value of Performance RSUs granted$141.28 $94.99 $97.49 
Weighted average fair value of stock options granted$109.52 $60.85 $61.18 
Stock option assumptions:
Risk-free interest rate4.2 %3.6 %2.4 %
Expected life (in years)7.98.08.9
Expected volatility56.2 %57.2 %54.2 %
Expected dividends— — — 
Stock Options

The following table summarizes stock option award activity during fiscal 2025:
Stock Options
SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Life
(In years)		Aggregate Intrinsic Value
(In thousands)
Outstanding as of January 27, 2024
264,125 $70.18 
Granted27,680 $141.28 
Options exercised(180,494)$58.91 
Canceled— $— 
Outstanding as of January 25, 2025
111,311 $106.13 7.9$9,652 
Exercisable options as of January 25, 2025
31,071 $94.71 7.3$3,049 

The total amount of exercisable options as of January 25, 2025 presented above reflects the approximate amount of options expected to vest. The aggregate intrinsic values presented above represent the total pre-tax intrinsic values (the difference between the Company’s closing stock price of $192.84 on the last trading day of fiscal 2025 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on the last trading day of fiscal 2025. The amount of aggregate intrinsic value will change based on the price of the Company’s common stock. The total intrinsic value of stock options exercised was $20.9 million, $0.8 million, and $8.5 million for fiscal 2025, fiscal 2024, and fiscal 2023, respectively. We received cash from the exercise of stock options of $10.6 million, $1.1 million, and $4.6 million during fiscal 2025, fiscal 2024, and fiscal 2023, respectively. During fiscal 2025, we paid $18.6 million to tax authorities for payroll tax withholding obligations on the exercise of stock options.

RSUs and Performance RSUs

The following table summarizes RSU and Performance RSU award activity during fiscal 2025:
Restricted Stock
RSUsPerformance RSUs
Share UnitsWeighted Average Grant PriceShare UnitsWeighted Average Grant Price
Outstanding as of January 27, 2024
390,765 $74.89 431,190 $95.98 
Granted128,040 $154.13 170,526 $141.28 
Share units vested(199,657)$56.71 (146,702)$92.07 
Forfeited or canceled(18,322)$112.66 (88,581)$96.46 
Outstanding as of January 25, 2025
300,826 $121.35 366,433 $118.51 

The total number of granted Performance RSUs presented above consists of 117,938 target shares and 52,588 supplemental shares. During fiscal 2025, we added 712 supplemental shares and cancelled 66,685 supplemental shares of Performance RSUs, as a result of performance criteria for attaining those shares being partially met for the applicable performance periods. Approximately 109,415 supplemental shares outstanding as of January 25, 2025 will be canceled during the three months ending April 26, 2025 as a result of the fiscal 2025 performance period criteria being partially met. The total amount of Performance RSUs outstanding as of January 25, 2025 consists of 251,626 target shares and 114,807 supplemental shares.

The total fair value of restricted share units vested during fiscal 2025, fiscal 2024, and fiscal 2023 was $49.3 million, $29.6 million, and $18.4 million, respectively.